Palvella Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2025 | 1.16 M | $72.80 M | 66.71% | 10.51% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 822.40 K | $51.56 M | 15.11% | 7.44% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 722.40 K | $45.29 M | 0.00% | 6.54% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 541.54 K | $33.95 M | 100.00% | 4.90% |
| VANGUARD GROUP INC | 11/07/2025 | 494.66 K | $31.01 M | 201.97% | 4.48% |
| BLACKROCK, INC. | 11/12/2025 | 487.62 K | $30.57 M | 9.56% | 4.41% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 395.09 K | $24.77 M | 100.00% | 3.57% |
| WOODLINE PARTNERS LP | 11/14/2025 | 345.75 K | $21.68 M | -22.41% | 3.13% |
| FEDERATED HERMES, INC. | 11/03/2025 | 339.05 K | $21.25 M | 100.00% | 3.07% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 317.31 K | $19.89 M | 100.00% | 2.87% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 250.06 K | $15.68 M | 0.00% | 2.26% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 236.63 K | $14.83 M | 177.31% | 2.14% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 209.63 K | $13.14 M | -38.30% | 1.90% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2025 | 186.75 K | $11.71 M | 1,279.05% | 1.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 168.11 K | $10.54 M | -3.38% | 1.52% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 166.54 K | $10.44 M | 100.00% | 1.51% |
| MORGAN STANLEY | 11/14/2025 | 138.51 K | $8.68 M | 2.03% | 1.25% |
| STATE STREET CORP | 11/14/2025 | 137.25 K | $8.60 M | 67.36% | 1.24% |
| FMR LLC | 11/13/2025 | 110.45 K | $6.92 M | 108,180.39% | 1.00% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 106.91 K | $6.70 M | 100.00% | 0.97% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 95.26 K | $5.97 M | -23.95% | 0.86% |
| CLIO ASSET MANAGEMENT LLC | 10/21/2025 | 91.64 K | $5.74 M | 0.15% | 0.83% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 89.70 K | $5.62 M | 34.16% | 0.81% |
| AWM INVESTMENT COMPANY, INC. | 11/13/2025 | 69.42 K | $4.35 M | 0.00% | 0.63% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 67.42 K | $4.23 M | 100.00% | 0.61% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 64.75 K | $4.06 M | 100.00% | 0.59% |
| NORTHERN TRUST CORP | 11/14/2025 | 54.00 K | $3.39 M | -0.92% | 0.49% |
| ABRDN PLC | 11/07/2025 | 51.24 K | $3.21 M | 100.00% | 0.46% |
| ROYCE & ASSOCIATES LP | 11/12/2025 | 49.51 K | $3.10 M | -33.56% | 0.45% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2025 | 49.12 K | $3.08 M | -48.63% | 0.44% |
| INVESCO LTD. | 11/13/2025 | 48.61 K | $3.05 M | 100.00% | 0.44% |
| J. GOLDMAN & CO LP | 11/14/2025 | 40.69 K | $2.55 M | -27.71% | 0.37% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 11/14/2025 | 34.90 K | $2.19 M | 100.00% | 0.32% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 26.87 K | $1.68 M | -91.47% | 0.24% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 25.53 K | $1.60 M | 100.00% | 0.23% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 23.84 K | $1.49 M | 476,660.00% | 0.22% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 23.70 K | $1.49 M | 100.00% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 21.01 K | $1.32 M | 0.00% | 0.19% |
| MARINER, LLC | 11/14/2025 | 20.72 K | $1.30 M | 100.00% | 0.19% |
| UBS GROUP AG | 11/13/2025 | 20.44 K | $1.28 M | -52.63% | 0.18% |
| CRESSET ASSET MANAGEMENT, LLC | 11/12/2025 | 17.42 K | $1.09 M | -16.68% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 16.19 K | $1.01 M | 18.47% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 15.70 K | $984.23 K | 58.59% | 0.14% |
| NUVEEN, LLC | 11/12/2025 | 12.71 K | $796.48 K | 42.67% | 0.11% |
| DELTEC ASSET MANAGEMENT LLC | 10/24/2025 | 12.50 K | $783.63 K | 0.00% | 0.11% |
| CATALIO CAPITAL MANAGEMENT, LP | 11/14/2025 | 12.01 K | $752.91 K | 100.00% | 0.11% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 11.34 K | $711.09 K | 100.00% | 0.10% |
| JANE STREET GROUP, LLC | 11/14/2025 | 10.02 K | $627.97 K | 100.00% | 0.09% |
| APIS CAPITAL ADVISORS, LLC | 11/14/2025 | 10.00 K | $626.90 K | 100.00% | 0.09% |
| RHUMBLINE ADVISERS | 11/06/2025 | 9.87 K | $618.80 K | -0.85% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Palvella Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 108 institutional investors and hedge funds held shares of Palvella Therapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 1.16 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 822,400
Frazier Life Sciences Management, L.P.: 722,400
First Light Asset Management, LLC: 541,544
VANGUARD GROUP INC: 494,656
BlackRock, Inc.: 487,616
77.13% of Palvella Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.54 M shares in the last 24 months. This purchase volume represents approximately $835.66 M in transactions.